Samuel Gerssen
Directeur/Membre du Conseil chez InteRNA Technologies BV
Profil
Samuel Gerssen currently works at Waterman 40 Holding BV, as Managing Director from 2015, InteRNA Technologies BV, as Member-Supervisory Board, and Alveron Pharma BV, as Member-Supervisory Board.
Postes actifs de Samuel Gerssen
Sociétés | Poste | Début |
---|---|---|
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Directeur/Membre du Conseil | - |
Waterman 40 Holding BV
Waterman 40 Holding BV Investment ManagersFinance Waterman 40 Holding BV (Waterman 40 Holding) is an Independent Private Equity/Venture Capital firm founded in 2015. The firm is headquartered in Maarsbergen. | Private Equity Investor | 01/01/2015 |
Alveron Pharma BV
Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Waterman 40 Holding BV
Waterman 40 Holding BV Investment ManagersFinance Waterman 40 Holding BV (Waterman 40 Holding) is an Independent Private Equity/Venture Capital firm founded in 2015. The firm is headquartered in Maarsbergen. | Finance |
Alveron Pharma BV
Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Health Technology |